37.41 USD
0 (0%)
37.41 USD
0 (0%)
Overall KEQU gets a fundamental rating of 5 out of 10. We evaluated KEQU against 186 industry peers in the Health Care Equipment & Supplies industry. KEQU has an average financial health and profitability rating. KEQU has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year KEQU was profitable.
KEQU had a positive operating cash flow in the past year.
In multiple years KEQU reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
1.2 Ratios
KEQU has a better Return On Assets (6.36%) than 86.02% of its industry peers.
KEQU has a better Return On Equity (18.34%) than 93.55% of its industry peers.
KEQU has a Return On Invested Capital of 10.92%. This is amongst the best in the industry. KEQU outperforms 90.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 8.84%.
The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 4.68%, KEQU is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
The Operating Margin of KEQU (7.60%) is better than 74.73% of its industry peers.
With a Gross Margin value of 29.37%, KEQU is not doing good in the industry: 76.34% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of KEQU has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
KEQU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
KEQU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KEQU is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.07 indicates that KEQU is not in any danger for bankruptcy at the moment.
KEQU's Altman-Z score of 3.07 is fine compared to the rest of the industry. KEQU outperforms 71.51% of its industry peers.
The Debt to FCF ratio of KEQU is 3.45, which is a good value as it means it would take KEQU, 3.45 years of fcf income to pay off all of its debts.
KEQU has a better Debt to FCF ratio (3.45) than 82.80% of its industry peers.
KEQU has a Debt/Equity ratio of 0.91. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
KEQU's Debt to Equity ratio of 0.91 is on the low side compared to the rest of the industry. KEQU is outperformed by 74.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.07 |
ROIC/WACC1.41
WACC7.73%
2.3 Liquidity
KEQU has a Current Ratio of 2.32. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
KEQU has a Current ratio (2.32) which is in line with its industry peers.
KEQU has a Quick Ratio of 1.63. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
KEQU has a Quick ratio (1.63) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
The earnings per share for KEQU have decreased strongly by -37.55% in the last year.
Measured over the past years, KEQU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.78% on average per year.
KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.02%.
Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.
EPS 1Y (TTM)-37.55%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%-19.15%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.41, the valuation of KEQU can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 96.77% of the companies listed in the same industry.
KEQU's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.41 | ||
| Fwd PE | N/A |
4.2 Price Multiples
97.31% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, KEQU is valued cheaper than 98.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.74 | ||
| EV/EBITDA | 5.96 |
4.3 Compensation for Growth
The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
37.41
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners41.14%
Inst Owner Change1.56%
Ins Owners15.96%
Ins Owner Change0.09%
Market Cap107.37M
Revenue(TTM)285.51M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %1.66%
Short Ratio3.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.41 | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 5.74 | ||
| P/OCF | 5.02 | ||
| P/B | 1.6 | ||
| P/tB | 2.89 | ||
| EV/EBITDA | 5.96 |
EPS(TTM)5.05
EY13.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY17.43%
OCF(TTM)7.45
OCFY19.9%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number51.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.07 |
F-Score4
WACC7.73%
ROIC/WACC1.41
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.55%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%-19.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.02%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 5 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.